08/14/2025
4:21 PM | Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
08/12/2025
3:16 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2025
3:02 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
11:15 PM | Lyra Therapeutics (Filer)
| Form EFFECT | |
07/22/2025
4:15 PM | Lyra Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/14/2025
8:27 PM | Cavalier Jason (Reporting)
Lyra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
8:27 PM | Lyra Therapeutics (Issuer)
Palasis Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
9:41 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
8:20 AM | Lyra Therapeutics (Filer)
| Form 424B5 | |
06/23/2025
6:00 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:00 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for LYRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/02/2025
6:22 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
2:41 PM | Lyra Therapeutics (Subject)
Waksal Harlan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025
2:44 PM | Lyra Therapeutics (Subject)
Palasis Maria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2025
7:59 AM | Lyra Therapeutics (Filer)
| Form DEF 14A | |
04/04/2025
8:01 AM | Lyra Therapeutics (Filer)
| Form DEFA14A | |
03/25/2025
3:30 PM | Lyra Therapeutics (Filer)
| Form PRE 14A | |
02/14/2025
5:22 PM | CITADEL ADVISORS LLC (Filed by)
Lyra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024
8:02 PM | Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/13/2024
4:06 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
5:39 PM | Lyra Therapeutics (Issuer)
Waksal Harlan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:54 PM | Lyra Therapeutics (Issuer)
Palasis Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:48 PM | Lyra Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:48 PM | Lyra Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:49 PM | Lyra Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:53 PM | Lyra Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
MarketBeat All Access